NEW YORK (GenomeWeb News) – Precision for Medicine, a Chevy Chase, Md.-based startup offering a variety of services for life science companies, has brought in $150 million in private funding, the firm said this week.

The company is focused on providing bioservices, such as biobanking, biospecimen management, and biomarker identification and validation, as well as consulting and advisory services for firms developing or offering products for "patient-centered, precision medicine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.